Page 34 - Lazard News Today

Have things changed at Bank of America?

Saga is exploring ways to release money from its ocean cruises operation which could involve selling its two flagship vessels or offloading the entire business under a licensing arrangement.

(Bloomberg) -- Tellurian Inc., which is seeking to export US natural gas, said it has hired Lazard Inc. to explore “commercial opportunities.” Options under consideration include a potential sale of the company, according to people familiar with the situation. Most Read from BloombergTesla Sinks After Warning About ‘Notably Lower’ Growth RatePutin Sends US Signal on Ukraine Talks, Sensing Advantage in WarUS GDP Grew 3.3% Last Quarter, Capping Unexpectedly Strong YearM...

JPMorgan Chase shuffled executives in its investment banking and consumer units on Thursday, giving them more experience running different businesses as Wall Street focuses on the banks succession...

The over-50s travel and insurance specialist could outsource the operation of its two ocean cruise ships under plans being explored by its board, Sky News learns.

(Bloomberg) -- Tellurian Inc., which is seeking to export US natural gas, said it has hired Lazard Inc. to explore “commercial opportunities.” Options under consideration include a potential sale of the company, according to people familiar with the situation. Most Read from BloombergPutin Sends US Signal on Ukraine Talks, Seeing War AdvantageOne of World’s Richest Doctors Sees Fortune Surge to $12 BillionJPMorgan Shuffles Top Managers as Jamie Dimon Prepares SuccessorsUN Co...

Brookfield Asset Management (NYSE:BAM – Get Free Report) and Lazard (NYSE:LAZ – Get Free Report) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation. Dividends Brookfield Asset Management pays an annual dividend […]

  Sanofi to acquire Inhibrx, Inc., adding potential best-in-class rare disease asset for Alpha-1 Antitrypsin Deficiency to pipeline Acquisition supports Sanofi’s portfolio growth...

Though they will only say so in private | World News

Inhibrx, Inc. shareholders will receive per share consideration of $30 per share in cash, a CVR equal to $5, plus 0.25 shares in New Inhibrx, a new publicly traded company that retains all non-101...